Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study-Reference-Cited by-同舟云学术

Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study

Published:2001-01 Issue:1 Volume:75 Page:46-52
ISSN:0015-0282
Container-title:Fertility and Sterility
language:en
Short-container-title:Fertility and Sterility

Author:

Glueck C.J,Phillips Harvey,Cameron Dan,Sieve-Smith Luann,Wang Ping

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Reproductive Medicine

Reference30 articles.

1. Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with polycystic ovary syndrome;Glueck;Metabolism,1999

2. Plasminogen activator inhibitor activity;Glueck;Metabolism,1999

3. Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein (a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome;Velazquez;Metabolism,1997

4. The plasminogen activator system in women with polycystic ovary syndrome;Atiomo;Fertil Steril,1998

5. Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) in lean women with and without the polycystic ovary syndrome;Sampson;Clin Endocrinol,1996

Cited by 336 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polycystic ovary syndrome and miscarriage: a narrative review;F&S Reviews;2024-10

2. Australasian Recurrent Pregnancy Loss Clinical Management Guideline 2024 Part I;Australian and New Zealand Journal of Obstetrics and Gynaecology;2024-06-27

3. Diagnostik Therapie bei gestörter Ovarfunktion;Klinische Endokrinologie für Frauenärzte;2024

4. An artificial intelligence-based decision support system for early diagnosis of polycystic ovaries syndrome;Healthcare Analytics;2023-11

5. Polycystic ovary syndrome and recurrent pregnancy loss, a review of literature;Frontiers in Endocrinology;2023-10-30